What is the success rate of Vidaza?

What is the success rate of Vidaza?

This analysis showed that 50 percent of the AML patients who were treated with VIDAZA survived at least two years, compared to only 16 percent of patients treated with CCR.

Can you go into remission with MDS?

Patients who get the higher-dose treatment are more likely to have their MDS go into remission, but they can also have more severe, even life-threatening side effects, so this treatment is typically given in the hospital. Still, this treatment may be an option for some patients with advanced MDS.

How long can you take Vidaza?

VIDAZA is not a one-time treatment. Treatment cycles are given every 28 days for as long as your doctor recommends them. It may take several cycles (about 4 to 6 months) for your doctor to notice a difference. If you stop receiving treatment, your symptoms may return.

How does Vidaza work for MDS?

Azacitidine is a type of drug called a hypomethylating agent. It works by switching off a protein called DNA methyltransferase. This switches on genes that stop the cancer cells growing and dividing. This reduces the number of abnormal blood cells and helps to control cell growth.

Can vidaza cure MDS?

How does VIDAZA treat MDS? When you have MDS, your bone marrow usually makes fewer healthy blood cells. The blood cells it does make don’t always work as they should. VIDAZA was the first drug approved by the US Food and Drug Administration (FDA) for the treatment of all 5 FAB subtypes of MDS.

How does Vidaza make you feel?

Common side effects of Vidaza include: febrile neutropenia, pneumonia, upper respiratory tract infection, abdominal pain, abdominal tenderness, anemia, anxiety, arthralgia, asthenia, back pain, chest pain, constipation, cough, depression, diarrhea, dizziness, dyspnea, dyspnea on exertion, epistaxis, fatigue, fever.

Is Vidaza considered chemo?

Azacitidine. Azacitadine is the generic name for the trade name drugs Vidaza or Onureg. In some cases, health care professionals may use trade name or the generic name when referring to the drug. Drug Type: Azacitadine is a cytotoxic chemotherapy drug.

How effective is Vidaza for myelodysplastic syndromes?

Vidaza Significantly Extends Overall Survival by 74% in Phase 3 Trial in Myelodysplastic Syndromes (MDS) Two year survival rate of 50.8 percent for Vidaza versus 26.2 for conventional care regimens 9.4 months median survival benefit for patients on Vidaza compared to conventional care regimens Only agent to demonstrate survival benefit in MDS

What is the survival rate for patients on Vidaza?

Two year survival rate of 50.8 percent for Vidaza versus 26.2 for conventional care regimens

What is the prognosis of myelodysplastic syndromes (MDS)?

The WHO Prognostic Scoring System (WPSS) risk groups can also be used to predict outcome – both median survival and the chance that the MDS will transform into acute myeloid leukemia (AML) within 5 years. These statistics were published in 2007 based on patients diagnosed between 1982 and 2004.

What are the benefits of Vidaza for AML?

Vidaza reduces the symptoms, reduce the risk of AML and improves the overall quality of life; it is safe and effective for elderly patients as well. Studies have shown that many patients benefit and live longer with Vidaza than with conventional treatment.